A Prospective Double-blind Interventional Study of Tissue Reaction to Polyglycolic Acid Sutures in Human Skin
1 other identifier
interventional
42
1 country
1
Brief Summary
Objective To investigate the tissue reaction produced by implanted polyglactin suture material in normal human skin and to determine the effect of suture gauge on this response. Design A prospective, double blind, randomized clinical trial using a novel ethical study design. Both the patient and clinician analyzing the histology were blinded to the suture gauge used. Participants A total of 42 consecutive patients presenting to an oculoplastic clinic with involutional entropion and horizontal eyelid laxity, who provided written consent to participate, were enrolled in the study. Intervention Patients were randomly allocated to 5/0 or 7/0 Vicryl™ test suture groups. Patient symptoms were alleviated during the wait for definitive surgery by the placement of temporary eyelid everting sutures including a test suture. After 28 days, entropion correction was achieved by a Quickert procedure which includes excision of an eyelid wedge. Histological analysis was carried out, blind to the suture gauge used, on the excised eyelid containing the test suture. Main outcome measure Defined histological parameters of suture-related granulomas were measured at multiple levels. Data included granuloma outer diameter, central cellular diameter, giant cell number and area of fibrous coat (calculated from the coat diameter and thickness at multiple levels) and a statistical comparison made between the 5/0 and 7/0 suture gauge groups.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jun 2010
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2011
CompletedFirst Submitted
Initial submission to the registry
May 11, 2012
CompletedFirst Posted
Study publicly available on registry
May 15, 2012
CompletedMay 15, 2012
May 1, 2012
7 months
May 11, 2012
May 14, 2012
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Suture associated granuloma outer diameter
Histological measurement of suture associated granuloma outer diameter on excised eyelid specimens, average of 6 sections examined
28 days
Suture associated granuloma central cellular element diameter
Histological measurement of suture associated granuloma central cellular element diameter on excised eyelid specimens, average of 6 sections examined
28 days
Suture associated granuloma fibrous coat area
Histological measurement of suture associated granuloma fibrous coat area on excised eyelid specimens, average of 6 sections examined
28 days
Suture associated granuloma giant cell number
Count of giant cells on average of 6 histological sections from excised eyelid specimens
28 days
Study Arms (2)
5/0 gauge vicryl suture
ACTIVE COMPARATORPatients randomly assigned to 5/0 gauge test everting suture
7/0 gauge vicryl suture
ACTIVE COMPARATORPatients randomly assigned to 7/0 gauge test everting suture
Interventions
7/0 vicryl test suture placed as one of 3 everting sutures
5/0 vicryl test suture placed as one of 3 everting sutures
Eligibility Criteria
You may qualify if:
- Consecutive patients
- Involutional lower eyelid entropion
- Horizontal eyelid laxity associated
- Informed consent
You may not qualify if:
- Inability to provide informed consent
- Previous eyelid surgery
- Poorly controlled diabetes
- Oral steroid use
- Addisons disease
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Royal Bournemouth Hospital
Bournemouth, Dorset, BH7 7DW, United Kingdom
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ben Parkin, MD
Royal Bournemouth Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Consultant Ophthalmologist
Study Record Dates
First Submitted
May 11, 2012
First Posted
May 15, 2012
Study Start
June 1, 2010
Primary Completion
January 1, 2011
Study Completion
March 1, 2011
Last Updated
May 15, 2012
Record last verified: 2012-05